| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $820.0M | +10.1% |
| Cost of Revenue | $370.0M | -2.7% |
| Gross Profit | $450.0M | +23.5% |
| R&D Expense | $30.6M | -5.3% |
| SG&A Expense | $341.9M | +13.9% |
| Operating Income | $74.0M | +731.5% |
| Interest Expense | $10.0M | +203.0% |
| Pre-tax Income | $65.2M | +1024.1% |
| Income Tax | $14.7M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $127.7M | +7.8% |
| Accounts Receivable | $167.9M | +28.0% |
| Inventory | $190.3M | +26.6% |
| Current Assets | $499.8M | +19.4% |
| Total Assets | $1.79B | +12.1% |
| Current Liabilities | $185.8M | +33.5% |
| Long-term Debt | $226.3M | +74.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $90.9M | +4.1% |
| Investing Cash Flow | -$135.4M | -544.8% |
| Financing Cash Flow | $56.7M | +202.5% |
| +2350.0% |
| Net Income | $50.5M | +871.2% |
| EPS (Basic) | $1.08 | +881.8% |
| EPS (Diluted) | $1.07 | +872.7% |
| Total Liabilities |
| $495.7M |
| +49.9% |
| Stockholders' Equity | $1.29B | +2.2% |